Camarda Financial Advisors, LLC Amgen Inc Transaction History

Camarda Financial Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $210,249 - $267,147	918 Added 12.26%	8,404 $2.21 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $2.58 Million - $2.91 Million	-11,488 Reduced 60.55%	7,486 $1.69 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $2.07 Million - $2.3 Million	8,957 Added 89.42%	18,974 $4.62 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $1.19 Million - $1.32 Million	5,426 Added 118.19%	10,017 $2.42 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $18,679 - $21,885	-88 Reduced 1.88%	4,591 $976,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $3,270 - $3,627	-14 Reduced 0.3%	4,679 $1.14 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $19,528 - $22,756	88 Added 1.91%	4,693 $1.17 Million
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $3,894 - $4,638	18 Added 0.39%	4,605 $1.06 Million
Q1 2019 Apr 25, 2019	SELL	$180.87 - $203.88 $3,255 - $3,669	-18 Reduced 0.39%	4,587 $871,000
Q4 2018 Jan 23, 2019	BUY	$178.4 - $208.25 $3,211 - $3,748	18 Added 0.39%	4,605 $896,000
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $18,229 - $20,367	-108 Reduced 2.3%	4,587 $798,000
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $785,426 - $896,745	4,695	4,695 $875,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Camarda Financial Advisors, LLC with notifications on news.